A new competitive threat is emerging for International Business Machines Corp. (IBM) within one of its most entrenched and profitable service lines. The arena is the complex modernization of aging COBOL systems that run on mainframe computers, a domain long dominated by IBM’s specialized consulting. The challenger is AI specialist Anthropic, which claims its new artificial intelligence tool can dramatically accelerate this very work. This development is focusing investor attention on risks to a segment that has historically provided IBM with stable, “sticky” revenue streams.
Investor Sentiment Reflects Mounting Concerns
The market’s reaction to this potential shift has been notably anxious. IBM’s share price remains under pressure following recent declines, currently trading at 202.30 euros. A telling technical indicator is the stock’s position below key moving averages, signaling that the investment community views this as a substantive issue rather than a minor footnote. The underlying logic is clear: if AI can genuinely simplify the modernization process, it could reduce the deep client dependency on specialized service providers like IBM. That very dependency has been a central protective moat within the mainframe ecosystem for decades.
The Stakes: COBOL’s Critical Yet Cumbersome Legacy
COBOL remains the operational backbone for critical applications across major financial institutions, government agencies, and airlines. The systems’ modernization, however, is famously complex, costly, and fraught with risk. This difficulty has historically played to IBM’s advantage, as clients have had little choice but to rely on its intensive, expert-driven support services. Anthropic is now positioning its AI offering as a shortcut. The tool, part of the “Claude Code” suite, promises to automate and speed up the updating of legacy COBOL code. According to the company’s announcement, a process that traditionally could take years might be condensed into just a few quarters. Such a capability represents a direct assault on the consulting and modernization services that have been reliable income generators for IBM.
Should investors sell immediately? Or is it worth buying IBM?
IBM’s Counter-Strategy: Leveraging Its Own AI Platform
In response, IBM is highlighting its own AI-powered modernization initiatives. The company prominently points to its watsonx platform, designed to help clients transform their COBOL-based systems. Concurrently, IBM is emphasizing the security and reliability arguments for maintaining mainframes, especially for business-critical applications. The broader, structural question now is how effectively IBM can pivot its own AI narrative from a defensive posture to a compelling growth story. The immediate catalyst was an Anthropic blog post, but the larger debate it triggers is about the automation of high-expertise tasks that have commanded premium fees.
The ultimate impact will hinge on two key factors: whether Anthropic’s approach delivers on its promises in real-world applications, and how successfully IBM can embed its own AI tools with its extensive existing customer base. The competition for the future of legacy system modernization has entered a new, technologically accelerated phase.
Ad
IBM Stock: Buy or Sell?! New IBM Analysis from March 3 delivers the answer:
The latest IBM figures speak for themselves: Urgent action needed for IBM investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 3.
IBM: Buy or sell? Read more here...









